CT and serum LDH shows promise as survival predictor for some metastatic melanoma patients
Wednesday, April 17, 2013 - 09:31
in Health & Medicine
Combining CT imaging findings with baseline serum lactate dehydrogenase levels is showing promise as a way to predict survival in patients with metastatic melanoma being treated with anti-angiogenic therapy.